BMS to move 100 jobs from Syracuse; India nixes Gilead, Roche patent apps;

> Bristol-Myers Squibb says it will cut 100 jobs from its Syracuse-area operations by the end of 2010 as the drug maker consolidates its Drug Safety Evaluation group into facilities in Indiana and New Jersey. Report

> Indian officials have rejected patent applications for Gilead Sciences' Hespera and for Roche's Tarceva salts form, saying they're not novel and so don't qualify for exclusivity. Report

> Cephalon is updating the prescribing information for its cancer treatment drug Treanda to include a warning about the use of the drug with allopurinol, according to documents filed with the SEC. Report

> The United States is putting Finland on a special observation list over Finland's system of reference prices for pharmaceuticals. Report

> The UK branded pharmaceutical market looks set to decline from 2009 onwards as the volume of drugs remains flat but prices are cut, predicts a recent report by market analyst Datamonitor. Report

> The FDA has authorized the emergency use of antivirals and diagnostic tests to help fight the spread of swine flu in the United States. Report

> President Barack Obama asked Congress for $1.5 billion today to fight a new version of swine flu that is spreading in the U.S. and around the world. California Governor Arnold Schwarzenegger, meanwhile, declared a state of emergency after health officials began to probe the deaths of two people who may have been infected with swine flu. Report

> Switzerland's Novartis has received the genetic code for the new swine flu virus that is raising alarms around the globe. And it hopes to get a sample of the actual virus soon as it begins work on a new vaccine that will guard against the disease. Report

> Corey Goodman had been Pfizer's go-to guy for biotechnology. But now he's out. Report

> San Diego-based Ardea Biosciences is pocketing a $35 million upfront payment and stands to earn another $372 million in milestones from a cancer drug development pact that it struck with Bayer HealthCare. Report

And Finally... As expected, Kathleen Sebelius was confirmed as HHS chief and sworn in last evening; now she confronts the job of overseeing the government's efforts on swine flu. Report

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.